Related Experiment Video
Updated: Aug 17, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Long-term survival in patients with mild or moderate impairment of left ventricular contractility during routine
L Grinfeld1, J R Kramer, M Goormastic
1Servicio de Cardiologia Intervencionista, Instituto del Corazon, Hospital Italiano, Buenos Aires, Argentina.
Insights
Long-term survival is good for patients with mild left ventricular impairment. Moderate impairment indicates a need for closer monitoring to prevent heart failure and arrhythmias.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Clinical Research
Background:
- Long-term survival for patients with mild to moderate left ventricular contractility impairment, without coronary artery disease, is not well-documented.
- Prognosis is generally assumed to be favorable in this patient group.
Purpose of the Study:
- To assess long-term survival and event-free survival in patients with mild or moderate left ventricular contractility impairment.
- To identify clinical and hemodynamic factors influencing prognosis.
Main Methods:
- Study included 168 patients with angiographically confirmed mild/moderate left ventricular impairment and no other significant cardiac disease.
- Evaluated clinical data, ECGs, chest X-rays, lab results, and hemodynamic parameters (e.g., ejection fraction, regional wall motion).
- Long-term survival determined via actuarial analysis over a mean follow-up of 138 months.
Main Results:
- Patients with moderate impairment showed higher rates of dyspnea and abnormal ECGs compared to mild impairment.
- Mean ejection fraction was 57% in mild impairment and 47% in moderate impairment.
- 14-year actuarial survival was 92% for mild impairment versus 75% for moderate impairment (P=0.01).
Conclusions:
- Long-term prognosis is favorable for patients with mild generalized left ventricular impairment.
- Patients with moderate impairment require closer follow-up for potential arrhythmias and congestive heart failure.
Abstract:
Long-term survival in patients with mild to moderate impairment of left ventricular contractility in the absence of coronary artery disease has not been studied extensively but the prognosis is assumed to be good. One hundred sixty-eight patients with angiographic evidence of mild or moderate impairment of left ventricular contractility and no other significant cardiac disease at the time of routine diagnostic cardiac catheterization were studied to determine long-term survival and event-free survival. Clinical characteristics, electrocardiograms, chest X-rays, laboratory data, and hemodynamics including end-diastolic volume, end-systolic volume, stroke volume, ejection fraction, and regional wall motion at the time of catheterization were examined. Patients with moderate impairment were more likely to have dyspnea (P = 0.005) and an abnormal electrocardiogram (P = 0.006) than patients with mild impairment. Mean ejection fraction was 57% (P = 0.0001 vs. normal) in patients with mild impairment and was 47% (P = 0.0001 vs. normal) in patients with moderate impairment. Wall motion studies showed impairment to be generalized and more significantly abnormal in patients with moderate impairment. Survival at a mean of 138 months could be determined in 162 of the 168 patients (96%). Fourteen year actuarial survival was 92% for patients with mild impairment compared to 75% for patients with moderate impairment (P = 0.01). Long-term prognosis is good in patients found to have mild generalized impairment at the time of routine diagnostic cardiac catheterization. In patients with moderate impairment, closer follow-up to prevent arrhythmia and the onset of congestive heart failure appears to be warranted.
More Related Videos
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
08:49Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024